SAFC Biosciences. Inc.
13804 W. 107th Street
Lenexa, Kansas 66215
USA
Phone +1 913-469-5580
Toll free-USA 1 800-255-6032
Fax +1 913-469-5584
Europe
SAFC Biosciences Ltd.
Smeaton Road, West Portway
albicans (60193/-) -
Escherichia coli (25922/00013) -
References:
1. World Health Organisation (WHO) – fact sheet N°255
2. L. De Zutter et al., Comparison of four different selective media for
Anti-BAG-1, clone 3.10G3E2 H WB IH M IgG1 50 µg MAB4611 $210
Bak
Anti-Bak, NT H M WB IP IH Rb IgG 200 µg 06-536 $329
APOPTOPAK, (Anti-Bcl2, Bak, Bax) Miniature Set WB IP IC
. of
Steroid Biochem. 27:967-969.
3. Barnes, D. and Sato, G. (1980).
Analytical Biochem. 102:255-270.
4. Barnes, D. and Sato, G. (1980). Cell
22:649.
5. Bell, N. (1970). J. Clin. Invest.
trap: VOCARB 3000 “K” (24940-U)
purge: 40 mL/min at 25 °C for 11 min
dry purge: 1 min
desorption temp.: 210 °C for 1 min
desorption flow: 150 mL/min
bake.: 260 °C for 10 min
transfer line/valve temp
agarose gel electrophoresis (2%
TAE gel, Figure 1). The results of the mul-
tiplex-PCR showed a clear amplification
for each target: 180 bp for stx1, 255 bp
for stx2, 384 bp for eaeA, 534 bp for
hlyA, and
induces apoptosis in Rat-1 and PC12 cells.
5 mg
InSolution™MG-132 474791 Supplied as a 10 mM (1 mg / 210 µl) solution of MG-132
(Cat. No. 474790) in anhydrous DMSO.
1 mg
MG-132 (Z-LLL-CHO
1.01845.1000 1 L GL 99.8 2 0.02 0.0002 0.0002 240 (60%), 255 (85%),
280 (98%)1.01845.2500 2.5 L GL
1.01845.9010 10 L ST
1.01845.9030 30 L ST
1.01845.9185 185 L ST
1-Chloro butane 1.01692.1000 1 L GL 99.8
to ERK2 and prevents
its interaction with MEK (IC50 = 210 nM). Does not affect the activa-
tion of JNKs or p38. M.W. 3146.8.
Cat. No. 328005 1 mg $ 160
RReeff..:: Kelemen, B.R., et al. 2002. J. Biol
identification of
several breeds with low serum IgA concentrations. Vet Immunol
Immunopathol 2014; 160: 255–259.
31. Hill PB, Moriello KA, DeBoer DJ. Concentrations of total serum
IgE, IgA and IgG in atopic
Glutamate receptor NMDAR 2a G9038 2903 GRIN2A P NP_000824.1 ,NP_001127879.1 ,NP_001127880.1 y y y
255 ERP57 E5031 2923 PDIA3 M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A
Glutamate receptor NMDAR 2a G9038 2903 GRIN2A P NP_000824.1 ,NP_001127879.1 ,NP_001127880.1 y y y
255 ERP57 E5031 2923 PDIA3 M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A